Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2011, Article ID 276419, 8 pages
http://dx.doi.org/10.1155/2011/276419
Review Article

The Metabolic Syndrome and Mind-Body Therapies: A Systematic Review

Center for the Study of Complementary and Alternative Therapies, University of Virginia School of Nursing, P.O. Box 800782, Charlottesville, VA 22908-0782, USA

Received 22 December 2010; Accepted 18 March 2011

Academic Editor: H. Boeing

Copyright © 2011 Joel G. Anderson and Ann Gill Taylor. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Prevalence of Diabetes Worldwide, vol. 2011, World Health Organization, Lyon, France, 2011.
  2. J. C. Seidell, “Obesity, insulin resistance and diabetes—a worldwide epidemic,” British Journal of Nutrition, vol. 83, supplement 1, pp. S5–S8, 2000. View at Google Scholar · View at Scopus
  3. E. S. Ford, C. Li, and G. Zhao, “Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US,” Journal of Diabetes, vol. 2, no. 3, pp. 180–193, 2010. View at Publisher · View at Google Scholar
  4. A. A. Rizvi, “Type 2 diabetes: epidemiologic trends, evolving pathogenetic concepts, and recent changes in therapeutic approach,” Southern Medical Journal, vol. 97, no. 11, pp. 1079–1087, 2004. View at Google Scholar
  5. H. M. Perry III, “The endocrinology of aging,” Clinical Chemistry, vol. 45, no. 8, pp. 1369–1376, 1999. View at Google Scholar · View at Scopus
  6. B. O. Isomaa, P. Almgren, T. Tuomi et al., “Cardiovascular morbidity and mortality associated with the metabolic syndrome,” Diabetes Care, vol. 24, no. 4, pp. 683–689, 2001. View at Google Scholar · View at Scopus
  7. M. P. Reilly and D. J. Rader, “The metabolic syndrome: more than the sum of its parts?” Circulation, vol. 108, no. 13, pp. 1546–1551, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Isomaa, “A major health hazard: the metabolic syndrome,” Life Sciences, vol. 73, no. 19, pp. 2395–2411, 2003. View at Publisher · View at Google Scholar
  9. E. Caglayan, F. Blaschke, Y. Takata, and W. A. Hsueh, “Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways,” Current Opinion in Pharmacology, vol. 5, no. 2, pp. 135–142, 2005. View at Publisher · View at Google Scholar
  10. D. J. Brotman and J. P. Girod, “The metabolic syndrome: a tug-of-war with no winner,” Cleveland Clinic Journal of Medicine, vol. 69, no. 12, pp. 990–994, 2002. View at Google Scholar · View at Scopus
  11. R. A. DeFronzo and E. Ferrannini, “Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease,” Diabetes Care, vol. 14, no. 3, pp. 173–194, 1991. View at Google Scholar · View at Scopus
  12. D. E. Laaksonen, H. M. Lakka, L. K. Niskanen, G. A. Kaplan, J. T. Salonen, and T. A. Lakka, “Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study,” American Journal of Epidemiology, vol. 156, no. 11, pp. 1070–1077, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Sattar, A. Gaw, O. Scherbakova et al., “Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study,” Circulation, vol. 108, no. 4, pp. 414–419, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. H. M. Lakka, D. E. Laaksonen, T. A. Lakka et al., “The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men,” Journal of the American Medical Association, vol. 288, no. 21, pp. 2709–2716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. N. Stas, F. A. El-Atat, and J. R. Sowers, “Pathogenesis of hypertension in diabetes,” Reviews in Endocrine and Metabolic Disorders, vol. 5, no. 3, pp. 221–225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. L. E. Wold, D. Muralikrishnan, C. B. Albano, F. L. Norby, M. Ebadi, and J. Ren, “Insulin-like growth factor I (IGF-1) supplementation prevents diabetes-induced alterations in coenzymes Q and Q,” Acta Diabetologica, vol. 40, no. 2, pp. 85–90, 2003. View at Google Scholar · View at Scopus
  17. S. B. Wheatcroft, I. L. Williams, A. M. Shah, and M. T. Kearney, “Pathophysiological implications of insulin resistance on vascular endothelial function,” Diabetic Medicine, vol. 20, no. 4, pp. 255–268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Esler, M. Rumantir, G. Wiesner, D. Kaye, J. Hastings, and G. Lambert, “Sympathetic nervous system and insulin resistance: from obesity to diabetes,” American Journal of Hypertension, vol. 14, no. 11, 2001. View at Google Scholar · View at Scopus
  19. P. P. Vitaliano, J. M. Scanlan, J. Zhang, M. V. Savage, I. B. Hirsch, and I. C. Siegler, “A path model of chronic stress, the metabolic syndrome, and coronary heart disease,” Psychosomatic Medicine, vol. 64, no. 3, pp. 418–435, 2002. View at Google Scholar · View at Scopus
  20. K. Räikkönen, K. A. Matthews, and L. H. Kuller, “The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence?” Metabolism: Clinical and Experimental, vol. 51, no. 12, pp. 1573–1577, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. T. G. Pickering, D. Phil, L. Clemow, K. Davidson, and W. Gerin, “Behavioral cardiology—has its time finally arrived?” Mount Sinai Journal of Medicine, vol. 70, no. 2, pp. 101–112, 2003. View at Google Scholar · View at Scopus
  22. P. Björntorp, “Body fat distribution, insulin resistance, and metabolic diseases,” Nutrition, vol. 13, no. 9, pp. 795–803, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. P. H. Black and L. D. Garbutt, “Stress, inflammation and cardiovascular disease,” Journal of Psychosomatic Research, vol. 52, no. 1, pp. 1–23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Chan, K. Inouye, M. C. Riddell, M. Vranic, and S. G. Matthews, “Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis,” Minerva endocrinologica, vol. 28, no. 2, pp. 87–102, 2003. View at Google Scholar · View at Scopus
  25. R. von Känel, P. J. Mills, C. Fainman, and J. E. Dimsdale, “Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?” Psychosomatic Medicine, vol. 63, no. 4, pp. 531–544, 2001. View at Google Scholar · View at Scopus
  26. D. L. Musselman, E. Betan, H. Larsen, and L. S. Phillips, “Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment,” Biological Psychiatry, vol. 54, no. 3, pp. 317–329, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. P. N. Prinz, “Sleep and sleep disorders in older adults,” Journal of Clinical Neurophysiology, vol. 12, no. 2, pp. 139–146, 1995. View at Google Scholar
  28. T. Åkerstedt and P. M. Nilsson, “Sleep as restitution: an introduction,” Journal of Internal Medicine, vol. 254, no. 1, pp. 6–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Meisinger, M. Heier, and H. Loewel, “Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population,” Diabetologia, vol. 48, no. 2, pp. 235–241, 2005. View at Publisher · View at Google Scholar
  30. A. B. Newman, P. L. Enright, T. A. Manolio, E. F. Haponik, and P. W. Wahl, “Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health Study,” Journal of the American Geriatrics Society, vol. 45, no. 1, pp. 1–7, 1997. View at Google Scholar · View at Scopus
  31. P. M. Barnes, B. Bloom, and R. L. Nahin, “Complementary and alternative medicine use among adults and children: United States, 2007,” National Health Statistics Reports, no. 12, pp. 1–23, 2009. View at Google Scholar · View at Scopus
  32. K. E. Innes, C. Bourguignon, and A. G. Taylor, “Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review,” Journal of the American Board of Family Practice, vol. 18, no. 6, pp. 491–519, 2005. View at Google Scholar · View at Scopus
  33. B. K. Sahay, “Yoga and diabetes,” The Journal of the Association of Physicians of India, vol. 34, no. 9, pp. 645–648, 1986. View at Google Scholar · View at Scopus
  34. S. Singh, V. Malhotra, K. P. Singh, S. V. Madhu, and O. P. Tandon, “Role of Yoga in modifying certain cardiovascular functions in type 2 diabetic patients,” Journal of Association of Physicians of India, vol. 52, pp. 203–206, 2004. View at Google Scholar · View at Scopus
  35. L. Xin, Y. D. Miller, and W. J. Brown, “A qualitative review of the role of Qigong in the management of diabetes,” Journal of Alternative and Complementary Medicine, vol. 13, no. 4, pp. 427–433, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. S. Lee, K. W. Chen, K. M. Sancier, and E. Ernst, “Qigong for cancer treatment: a systematic review of controlled clinical trials,” Acta Oncologica, vol. 46, no. 6, pp. 717–722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. F. M. Vera, J. M. Manzaneque, E. F. Maldonado et al., “Biochemical changes after a qigong program: lipids, serum enzymes, urea, and creatinine in healthy subjects,” Medical Science Monitor, vol. 13, no. 12, pp. CR560–CR566, 2007. View at Google Scholar
  38. M. S. Lee, M. H. Pittler, R. Guo, and E. Ernst, “Qigong for hypertension: a systematic review of randomized clinical trials,” Journal of Hypertension, vol. 25, no. 8, pp. 1525–1532, 2007. View at Publisher · View at Google Scholar
  39. M. Paul-Labrador, D. Polk, J. H. Dwyer et al., “Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease,” Archives of Internal Medicine, vol. 166, no. 11, pp. 1218–1224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. G. Taylor, L. E. Goehler, D. I. Galper, K. E. Innes, and C. Bourguignon, “Top-down and bottom-up mechanisms in mind-body medicine: development of an integrative framework for psychophysiological research,” Explore, vol. 6, no. 1, pp. 29–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Liu, Y. D. Miller, N. W. Burton, and W. J. Brown, “A preliminary study of the effects of Tai Chi and Qigong medical exercise on indicators of metabolic syndrome, glycaemic control, health-related quality of life, and psychological health in adults with elevated blood glucose,” British Journal of Sports Medicine, vol. 44, pp. 704–709, 2010. View at Google Scholar
  42. D. Khatri, K. C. Mathur, S. Gahlot, S. Jain, and R. P. Agrawal, “Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome,” Diabetes Research and Clinical Practice, vol. 78, no. 3, pp. e9–e10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. B. E. Cohen, A. A. Chang, D. Grady, and A. M. Kanaya, “Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial,” Metabolic Syndrome and Related Disorders, vol. 6, no. 3, pp. 223–229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. G. Anderson and A. G. Taylor, “Effects of healing touch in clinical practice: a systematic review of randomized clinical trials,” Journal of Holistic Nursing. In press. View at Publisher · View at Google Scholar
  45. R. L. Bijlani, R. P. Vempati, R. K. Yadav et al., “A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus,” Journal of Alternative and Complementary Medicine, vol. 11, no. 2, pp. 267–274, 2005. View at Publisher · View at Google Scholar
  46. M. Vázquez-Vandyck, S. Roman, J. L. Vázquez et al., “Effect of breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome,” World Journal of Gastroenterology, vol. 13, no. 46, pp. 6213–6218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. D. G. Altman, K. F. Schulz, D. Moher et al., “The revised CONSORT statement for reporting randomized trials: explanation and elaboration,” Annals of Internal Medicine, vol. 134, no. 8, pp. 663–694, 2001. View at Google Scholar · View at Scopus
  48. S. F. Garcia, D. Cella, S. B. Clauser et al., “Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative,” Journal of Clinical Oncology, vol. 25, no. 32, pp. 5106–5112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. Patient Reported Outcomes Meas urement Information System (PROMIS), vol. 2010, http://www.nihpromis.org/Documents/PROMIS_The_First_Four_Years.pdf.
  50. M. S. Lee, M. H. Pittler, and E. Ernst, “Effects of reiki in clinical practice: a systematic review of randomised clinical trials,” International Journal of Clinical Practice, vol. 62, no. 6, pp. 947–954, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Yang, J. Verkuilen, K. S. Rosengren et al., “Effects of a Taiji and Qigong intervention on the antibody response to influenza vaccine in older adults,” American Journal of Chinese Medicine, vol. 35, no. 4, pp. 597–607, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. M. S. Lee, M. S. Lee, H. J. Kim, and S. R. Moon, “Qigong reduced blood pressure and catecholamine levels of patients with essential hypertension,” International Journal of Neuroscience, vol. 113, no. 12, pp. 1691–1701, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Bonadonna, “Meditation's impact on chronic illness,” Holistic Nursing Practic, vol. 17, no. 6, pp. 309–319, 2003. View at Google Scholar
  54. K. G. Walton, R. H. Schneider, J. W. Salerno, and S. I. Nidich, “Psychosocial stress and cardiovascular disease part 3: clinical and policy implications of research on the Transcendental Meditation program,” Behavioral Medicine, vol. 30, no. 4, pp. 173–183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. M. V. Rainforth, R. H. Schneider, S. I. Nidich, C. Gaylord-King, J. W. Salerno, and J. W. Anderson, “Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis,” Current Hypertension Reports, vol. 9, no. 6, pp. 520–528, 2007. View at Publisher · View at Google Scholar · View at Scopus